Follow the question back to the paper
The papers behind these pages, with a small note on what each can tell us. Follow whichever question interests you.
Hormones, meals and the exact substance
How ipamorelin releases growth hormone
Early animal work explains the action. It doesn’t tell us whether people sleep better or recover faster.
A short hormone response to ipamorelin
Healthy men received ipamorelin into a vein. The hormone response was short; everyday benefits weren’t tested.
Ipamorelin after bowel surgery
Patients received ipamorelin into a vein. The study didn’t find clear evidence that it helped them tolerate a meal sooner.
Long-acting CJC-1295 in healthy adults
Growth hormone and the related signal IGF-1 stayed higher for days. That doesn’t establish better health.
Growth hormone pulses during CJC-1295 stimulation
Growth hormone still arrived in bursts in healthy men. Keeping that rhythm doesn’t establish long-term safety.
Identifying CJC-1295 in an unknown preparation
The researchers identified a substance in one preparation. That finding doesn’t vouch for another preparation or its effects.
Energy readings, cells and mice
What NAD+ does as cells age
Background on NAD+ in energy use, repair and signalling. A molecule’s job doesn’t establish a treatment’s benefit.
Oral NR and blood NAD+
NR raised blood NAD+ in healthy overweight adults. A blood result isn’t a finding about every organ.
NMN and the response to insulin
After oral NMN, muscle responded better to insulin in prediabetic postmenopausal women. Body composition and longer-term blood sugar didn’t change.
The limits of human NAD+ precursor research
Blood changes are clearer than health benefits. The review also finds little evidence about what happens in specific tissues.
MOTS-c moving inside stressed cells
MOTS-c moved into the nucleus and affected gene activity in cell experiments. These weren’t human treatment results.
MOTS-c and physical performance in mice
Giving MOTS-c improved performance in mice. The paper also studied exercise-related changes in the body’s own MOTS-c.
MOTS-c, metabolism and stress
Background on where this peptide comes from and how it may work. Human treatment benefits remain unproved.
Safety and the meaning of approval
FDA’s closer look at ipamorelin
The review includes two deaths after bowel-surgery complications; whether ipamorelin contributed is unclear. It also flags missing safety data for injections under the skin.
FDA’s review of CJC-1295 forms
The exact preparation used in the human studies wasn’t clear, though it appeared to include DAC. The review also explains the different forms and safety concerns.
FDA’s safety concerns and withdrawn requests
The page dated April 22, 2026 lists withdrawn nominations separately. Ipamorelin acetate also retains a Category 2 entry for 503B.
What compounding means for FDA approval
Compounded medicines aren’t FDA-approved. FDA doesn’t review their safety, effectiveness or quality before marketing. A prescription doesn’t change that.
The link is a starting point
A paper can be useful without supporting every claim made about its subject. I look for the people or animals studied, the preparation and the outcome. The comparison shows why those details matter. There’s no need to read everything here in one sitting.